24/7 Market News Snapshot 04 March, 2025 – 908 Devices Inc. Common Stock (NASDAQ:MASS)

March 4, 2025

DENVER, Colo., 04 March, 2025 (247marketnews.com) – (NASDAQ:MASS) are discussed in this article.
908 Devices Inc. is generating significant attention in the financial market, with its pre-market trading showcasing a noteworthy surge to $3.122, marking an impressive increase of 57.68% from the previous close of $1.980. This robust performance has been underpinned by an active trading volume of 2.29 million shares, reflecting strong investor interest and potential for further upward movement, as indicated by favorable technical indicators. Market analysts are closely monitoring this momentum, considering the possibility of a substantial breakthrough for 908 Devices.

Simultaneously, Repligen Corporation has announced a strategic acquisition of 908 Devices’ desktop portfolio, which comprises four advanced analytical devices, aimed at bolstering its process analytical technology (PAT) capabilities. This acquisition, valued at $70 million, is in line with Repligen’s objective to enhance offerings for biopharmaceutical and contract development organizations, facilitating optimized development processes and improved manufacturing efficiencies.

Among the devices acquired are MAVERICK and MAVEN, which provide real-time monitoring of essential bioprocess parameters, alongside REBEL, an at-line cell culture media analyzer, and ZipChip, a high-resolution sample separation device crucial for assessing product quality attributes. The integration of these innovative tools is expected to enhance Repligen’s existing analytical portfolio and support the evolving demands of bioprocessing modalities.

Olivier Loeillot, President and CEO of Repligen, emphasized the significance of this acquisition, highlighting the onboarding of 908 Devices’ skilled team and their advanced technologies. Concurrently, Kevin J. Knopp, CEO and co-founder of 908 Devices, expressed confidence that this partnership will allow for an intensified focus on developing handheld technologies for critical health and safety applications, thereby setting the stage for growth and innovation in the bioprocessing sector.

Related news for (MASS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.